Tony Chou

Dr. Chou has been a general partner at The Vertical Group, a healthcare-focused venture capital firm, since August 2006, and Chief Executive Officer of Route 92 Medical, Inc. since October 2015. After joining The Vertical Group, Dr. Chou co-founded Silk Road in 2007 and served as CEO until November 2010. Prior to that, Dr. Chou had general management and business development responsibilities in the Abbott Vascular Division of Abbott Laboratories, and last served as Division Vice President and General Manager of vascular closure, managing the FDA approval and global launch of the Perclose and Starclose products. Dr. Chou was previously the Director of the Adult Cardiac Catheterization Laboratory at the University of California, San Francisco, where he is currently an Associate Professor of Medicine.

Dr. Chou received a B.S. in physics and electrical engineering from Carnegie Mellon and an M.D. from Case Western Reserve University.